April 29th 2025
New guidelines on GSM recommends symptom-based diagnosis, shared decision-making, and local estrogen as first-line therapy to improve quality of life.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Obesity Associated With Risk of Dissimilar Breast Cancers
March 24th 2011High body mass index (BMI) and low levels of physical activity are associated with increased risk of triple-negative and estrogen receptor-positive (ER+) breast cancers in postmenopausal women, according to a study published online March 1 in Cancer Epidemiology, Biomarkers & Prevention.
Read More
U.S. Breast Cancer Incidence Rates Stabilized After 2003
March 21st 2011Breast cancer incidence rates among non-Hispanic (NH) white women in the United States stabilized between 2003 and 2007 after a sharp decline between 2002 and 2003 that followed a drop in the use of postmenopausal hormone therapy, according to a study published online Feb. 28 in Cancer Epidemiology, Biomarkers & Prevention.
Read More
Timing of Hormone Therapy Influences Breast Cancer Risk
March 14th 2011For women taking postmenopausal hormone therapy, breast cancer risk is greater among users of estrogen-progestin formulations, and those who begin treatment earlier, according to a study published online Jan. 28 in the Journal of the National Cancer Institute.
Read More
Oral Bisphosphonates May Lower Colorectal Cancer Risk
March 8th 2011Use of oral bisphsphonates ofr more than one year in postmenopausal women is associated with a 59 percent decrease in the relative risk of colorectoal cancer, according to a study published online Feb. 14 in the Journal of Clinical Oncology.
Read More
Nitroglycerin Strengthens Bones in Older Women
March 1st 2011Nitroglycerin ointment appears to increase bone mineral density (BMD) and decrease bone resorption in postmenopausal women when administered daily, according to research published in the Feb. 23 issue of the Journal of the American Medical Association.
Read More
Menopausal Symptoms Linked to Lower Risk of Breast Cancer
February 10th 2011Women who experience menopausal symptoms and have increased intensity of hot flushes have a reduced risk of postmenopausal breast cancer, according to a study published online Jan. 6 in Cancer Epidemiology, Biomarkers & Prevention.
Read More
Escitalopram Successfully Reduces Hot Flashes
February 2nd 2011Menopausal women treated with the selective serotonin reuptake inhibitor escitalopram have fewer, and less severe, hot flashes than women taking a placebo, according to a study published in the Jan. 19 issue of the Journal of the American Medical Association.
Read More
North American Menopause Society: Treasuring the Past – Shaping the Future
September 20th 2006Sixteen years since its inception, The North American Menopause Society has become the leading organization focused on promoting the health and quality of life for women through an understanding of menopause. The organization has experienced phenomenal growth through the years, and present-day NAMS leaders look to the future with confidence.
Read More
Menopause and Cocktails: Good for Patient/Good for Practice
September 20th 2006Hot flashes, itchy skin, mood swings, and memory lapses – when the symptoms of menopause and perimenopause appear, they create a barrage of questions in women's minds struggling to prepare for this life milestone. When will my periods completely disappear?
Read More
Menopause and Osteoporosis: Options for Treatment
September 20th 2006A lot of options are available for menopause treatment, options that can be tailored to each individual woman. Women do need to have some guidelines about menopause, what to expect, and what that means. At this stage of their life, many female patients visit their physician not just because of symptoms they’re experiencing that are troubling them, but also because of an overall concern about entering menopause.
Read More